Narinder Pal Bhalla
Chief Medical Officer · Lexeo Therapeutics, Inc.
- 2026
- Sep 28, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Narinder Pal Bhalla files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Richard Nolan Townsend - $656K in LXEO purchases and sales in the last 12 months
- Jose Manuel Otero - $79K in LXEO purchases and sales in the last 12 months
- Louis Edward Tamayo - $41K in LXEO purchases and sales in the last 12 months
- Tai Sandi See - $38K in LXEO purchases and sales in the last 12 months
- Jenny Robertson - $37K in LXEO purchases and sales in the last 12 months
- Eric Adler - $36K in LXEO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Narinder Pal Bhalla?
Narinder Pal Bhalla is a corporate insider, tracked as Chief Medical Officer of Lexeo Therapeutics, Inc. (LXEO). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Narinder Pal Bhalla submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Narinder Pal Bhalla been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($99K) across all tracked filings.
